Doctor Arief Rahadian
Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima (Japan)
Arief Rahadian MD, graduated from Diponegoro University, Indonesia and continue his study as PhD at Tokushima University, Japan, in the Cardiovascular Department since 2017.
Glycemic control with canagliflozin, a SGLT-2 inhibitor, attenuates atherosclerosis and endothelial dysfunction in diabetic apolipoprotein e-deficient mice
Event: ESC Congress 2019
Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis
Session: Lipids and metabolism
ESC 365 is supported by
